These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28236652)

  • 1. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
    Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
    Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume dependence in hypoxia-targeted dose escalation.
    Chvetsov AV; Zeng J; Rajendran JG
    Med Phys; 2018 Nov; 45(11):5325-5331. PubMed ID: 30192391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological effectiveness of uniform and nonuniform dose distributions in radiotherapy for tumors with intermediate oxygen levels.
    Chvetsov AV; Pugachev A
    Biomed Phys Eng Express; 2024 Oct; 10(6):. PubMed ID: 39419065
    [No Abstract]   [Full Text] [Related]  

  • 4. A radiobiological model of reoxygenation and fractionation effects.
    Guerrero M; Carlson DJ
    Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume effects in the TCP for hypoxic and oxygenated tumors.
    Chvetsov AV; Stewart RD; Kim M; Meyer J; Rengan R
    Med Phys; 2020 Sep; 47(9):4626-4633. PubMed ID: 32452034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
    Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
    Zhang H; Zhong H; Barth RF; Cao M; Das IJ
    Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C; Papiez L; Zhang S; Story M; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes.
    Chvetsov AV; Hanin LG; Stewart RD; Zeng J; Rengan R; Lo SS
    Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34030139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after Hypofractionation.
    Zhang H; Wan C; Huang J; Yang C; Qin Y; Lu Y; Ma J; Wu B; Xu S; Wu G; Yang K
    Radiat Res; 2018 Dec; 190(6):584-595. PubMed ID: 30234458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
    Lindblom E; Dasu A; Toma-Dasu I
    Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
    Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
    Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple mathematical model of cyclic hypoxia and its impact on hypofractionated radiotherapy.
    Taylor E
    Med Phys; 2023 Mar; 50(3):1893-1904. PubMed ID: 36594511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
    Ruggieri R
    Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-fraction simulation of relative cell survival in response to uniform versus hypoxia-targeted dose escalation.
    Axente M; Lin PS; Pugachev A
    Phys Med Biol; 2012 May; 57(9):2757-74. PubMed ID: 22507874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The radiobiology of hypofractionation.
    Nahum AE
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
    Chan MKH; Chiang CL
    Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
    Ruggieri R; Nahum AE
    Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.